Pain analysis in patients with hepatocellular carcinoma: Irreversible electroporation versus radiofrequency ablation - Initial observations

CardioVascular and Interventional Radiology

Volumn 36, Issue 1, 2013, Pages 176-182

  Narayanan, Govindarajan ^a   Froud, Tatiana ^a   Lo, Kaming ^a   Barbery, Katuska J ^a   Perez Rojas, Evelyn ^a   Yrizarry, Jose ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Irreversible electroporation; Pain; Radiofrequency ablation

Indexed keywords

HYDROMORPHONE;

ADULT; AGED; ARTICLE; BURN; CANCER PATIENT; CANCER SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPORATION; FEMALE; HEMATOTHORAX; HUMAN; HUMAN TISSUE; INSTITUTIONAL REVIEW; IRREVERSIBLE ELECTROPORATION; LIVER CELL CARCINOMA; MALE; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PLEURA EFFUSION; PNEUMOTHORAX; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PRIMARY TUMOR; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RATING SCALE; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT DURATION;

AGE FACTORS; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DISEASE-FREE SURVIVAL; ELECTROCHEMOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PAIN; PAIN MANAGEMENT; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84872680334     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0426-9     Document Type: Article

References (18)

1. MedlinePlus. National Library of Medicine, Bethesda, MD. Hepatocellular carcinoma. http://www.nlm.nih.gov/medlineplus/ency/article/000280.htm. Accessed 30 May 2012
2. Davalos RV, Mir IL, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223-231
3. Lee EW, Chen C, Prieto VE et al (2010) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255:426-433
4. Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality - clinical implications. Technol Cancer Res Treat 6:37-48
5. Teratani T, Yoshida H, Shiina S et al (2006) Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 43:1101-1108
6. Mahvi DM, Lee FT Jr (1999) Radiofrequency ablation of hepatic malignancies: is heat better than cold? Ann Surg 230:9-11
7. Goldberg SN, Dupuy DE (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities, part 1. J Vasc Interv Radiol 12:1021-1032
8. Onik G, Mikus P, Rubinsky B (2007) Irreversible electroporation: implications for prostrate ablation. Technol Cancer Res Treat 6:295-300
9. Maor E, Ivorra A, Rubinsky B (2009) Non thermal irreversible electroporation: novel technology for vascular smooth muscle cell ablation. PLoS One 4(e4757):1-9
10. Maor E, Rubinsky B (2010) Endovascular non-thermal irreversible electroporation: a finite element analysis. ASME J Biomech Eng 132:031008
11. Maor E, Ivorra A, Leor J, Rubinsky B (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6:307-312
12. Dupuy DE, Aswad B, Ng T (2011) Irreversible electroporation in a swine lung model. Cardiocasc Intervent Radiol 34:391-395
13. Lee EW, Thai S, Kee ST (2010) Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver 4:99-104
14. Neal RE 2nd, Singh R, Hatcher HC et al (2010) Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Breast Cancer Res Treat 123:295-301
15. Charpentier KP, Wolf F, Noble L et al (2010) Irreversible electroporation of the pancreas in swine: a pilot study. HPB 12:348-351
16. Thomson KR, Cheung W, Ellis SJ et al (2011) Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 22:611-621
17. Ball C, Thomson KR, Kavnoudias H (2010) Irreversible electroporation: a new challenge in "out of operating theater" anesthesia. Anesth Analg 110:1305-1309
18. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208-1236